Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06956521 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Intra-Arterial Magnesium Therapy After Mechanical Thrombectomy in Acute Ischemic Stroke

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Jun 2026 → Jul 2027
See other at-risk trials from Baylor College of Medicine

Record History

  1. Primary completion pushed from Jun 2026 to Jul 2027 Recruitment opened · Start date changed from estimate of Jun 2025 to Jul 1, 2026 · Completion pushed from Jul 2026 to Jul 2027 · 4 more Show 7 more changesShow less
    • Recruitment opened
    • Start date changed from estimate of Jun 2025 to Jul 1, 2026
    • Completion pushed from Jul 2026 to Jul 2027
    • Study sites: 0 to 1
    • Eligibility criteria expanded, about 19 words
    • Secondary endpoints: details revised at 3 of 6 entries
    • Publications: details revised at 19 of 20 entries
  2. Secondary endpoints revised (6) Study description expanded, about 2 wordsv2 Show 1 more changeShow less
    • Study description expanded, about 2 words

    See this version in full on ClinicalTrials.gov ↗

  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this Phase I unblinded, dose-escalation trial is to evaluate the safety and tolerability of intra-arterial magnesium sulfate injection after mechanical thrombectomy in patients experiencing acute ischemic stroke. This trial is one of the first trials to look at IA administration of magnesium sulfate into at risk brain tissue in a selective and localized fashion.
Trial Details
NCT Number NCT06956521
Lead Sponsor Baylor College of Medicine
Conditions Acute Ischemic Stroke
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov